News

When and why to consider the diagnosis of myasthenia gravis in neurological practice, and what treatment options do we currently have?

2. 5. 2023 Source: Rare Diseases in Neurology

Myasthenia gravis (MG) is a clinically heterogeneous disease characterized by fluctuating muscle weakness and fatigability that worsens after physical exertion or mental stress. Accurate diagnosis is essential because treatment can lead to permanent remission and full functional capacity of the patient.

Sjögren's Syndrome as a Cause of Dry Eye Syndrome

Primary Sjögren's syndrome represents a complex autoimmune disease primarily affecting glands with exocrine secretion. Dry eye syndrome ranks among the most common difficulties for patients with…

2. 5. 2023 Source: Ophthalmologic Diseases

Infographic and Commentary from Practice: Reasons and Pathways for Patients to Biological Treatment of Asthma

For asthma patients with the most severe forms of the disease to access targeted biological treatment, they must undergo examination at one of the specialized centers for severe asthma. To facilitate…

28. 4. 2023 Source: Systemic treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis – Type 2 inflammation

Subcutaneous pdC1-INH in Patients with Hereditary Angioedema in Real-World Practice

Italian authors published a series of cases of patients with hereditary angioedema caused by C1 inhibitor deficiency (C1-INH-HAE) with long-term prophylaxis using human plasma-derived C1 inhibitor concentrate...

27. 4. 2023 Source: Hereditary Angioedema

Efficacy and Safety of an Activated FXII Inhibitor in Preventing HAE Attacks

Hereditary angioedema (HAE) is a rare, potentially life-threatening inherited disorder characterized by dysregulation of the kallikrein-kinin system. This results in excessive production of bradykinin,...

27. 4. 2023 Source: Hereditary Angioedema

To what extent does the delay between symptom onset and diagnosis of AATD affect patient survival?

The risk of chronic obstructive pulmonary disease (COPD) is increased, among other things, by a deficiency of alpha-1-antitrypsin (AATD). However, there is often a delay between the onset of symptoms...

26. 4. 2023 Source: Deficiency of Alpha-1-Antitrypsin

Augmentation Therapy of Bronchiectasis Due to AATD –⁠ Case Report

Alpha-1-antitrypsin deficiency (AATD) is a rare cause of bronchiectasis unrelated to cystic fibrosis. The role of augmentation therapy with alpha-1-antitrypsin (AAT) in patients with AATD with bronchiectasis...

26. 4. 2023 Source: Deficiency of Alpha-1-Antitrypsin

Pregnancy and Childbirth in a Woman with VWD −⁠ A Case Study

Pregnancy and childbirth are relatively demanding periods and situations for women with von Willebrand disease (vWD) from the perspective of hemostasis. They can be associated with an increased risk of...

26. 4. 2023 Source: Von Willebrand Disease

Benefits and Cost-Effectiveness of Superabsorbent Dressings in the Treatment of Venous Leg Ulcers

A recent cost-effectiveness analysis based on German data showed that using superabsorbent dressings instead of conventional dressings in the treatment of venous leg ulcers with moderate to high…

26. 4. 2023 Source: Wound Healing

Brain implants can affect the human mind in a surprising way

The technology company Neuralink, owned by Elon Musk, announced in December 2022 that it plans to start clinical testing of an electronic chip to be implanted in the skull within six months. However,…

26. 4. 2023 Source: medScope.pro

1 … 44 45 46 47 48 … 170

Back Filter by speciality

Remove filters